E3	Condition:T3 Name:T4 Severity:T60
E5	Condition:T5 Name:T6
E7	Condition:T7 Name:T8
E9	Condition:T9 Name:T10
E11	Condition:T11 Name:T12 Severity:T64
E13	Condition:T13 Name:T14
E15	Condition:T15 Name:T16
E17	Observation:T17 Name:T18 Eq-Comparison:E25
E19	Condition:T19 Name:T20
E20	Age:T29 Eq-Comparison:E23
E21	Eq-Comparison:T37 Operator:T21 Value:T30 Temporal-Unit:T46
E22	Eq-Comparison:T38 Operator:T22 Unit:T28 Value:T32 Per:T58
E23	Eq-Comparison:T39 Operator:T23 Temporal-Unit:T27 Value:T33
E24	Eq-Comparison:T40 Operator:T24 Value:T34
E25	Eq-Comparison:T41 Operator:T25 Value:T35
E26	Eq-Comparison:T42 Operator:T26 Value:T36 Temporal-Unit:T81
E2	Condition:T43 Name:T44 Severity:T1
E1	Condition:T2 Name:T45 Temporality:E21
E4	Drug:T47 Name:T48 Dose:E12
E6	And:T49 Arg:E1 Arg2:E4
E8	Modifier:T50 Modifies:E1
E10	And:T51 Arg:E2 Arg2:E1
E12	Eq-Comparison:T52 Operator:T53 Value:T31 Per:T55 Unit:T54
E14	Observation:T56 Name:T57 Eq-Comparison:E22
E16	And:T59 Arg:E4 Arg2:E14
E18	Modifier:T61 Modifies:T8
E27	Modifier:T62 Modifies:T8
E28	Or:T63 Arg:E18 Arg2:E27
E29	Observation:T65 Name:T66 Eq-Comparison:E24
E30	And:T67 Arg:E29 Arg2:E17
E31	Condition:T68 Name:T69 Temporality:E35
E32	Modifier:T70 Modifies:T69
E33	Modifier:T71 Modifies:T69
E34	Or:T72 Arg:E32 Arg2:E33
E35	Eq-Comparison:T73 Temporal-Period:T74
E36	Modifier:T75 Modifies:E9
E37	Death:T76
E38	Risk:T77 Risk-For:E37
E39	Observation:T78 Name:T79 Eq-Comparison:E26
E40	And:T80 Arg:E38 Arg2:E39
E41	Drug:T82 Name:T83
E43	Condition:T86 Name:T87
E44	Modifier:T88 Modifies:E43
E45	Modifier:T89 Modifies:E43
E46	Or:T90 Arg:E44 Arg2:E45
E42	Study:T85
E47	Other:T91 Is-Other:E42
T3	Condition 279 259	cardiopulmonary disease
T4	Condition-Name 279 259	cardiopulmonary disease
T5	Condition 344 322	coronary artery disease
T6	Condition-Name 344 322	coronary artery disease
T7	Condition 318 297	heart disease
T8	Condition-Name 318 297	heart disease
T9	Condition 501 466	kidney disease
T10	Condition-Name 501 466	kidney disease
T11	Condition 379 354	coagulopathy
T12	Condition-Name 379 354	coagulopathy
T13	Condition 473 438	Pregnancy
T14	Condition-Name 473 438	Pregnancy
T15	Condition 351 328	COPD
T16	Condition-Name 351 328	COPD
T17	Observation 409 380	INR
T18	Observation-Name 409 380	INR
T19	Condition 680 642	Hemodynamic instability
T20	Condition-Name 680 642	Hemodynamic instability
T21	Eq-Operator 85 80	<
T22	Eq-Operator 157 146	>
T23	Eq-Operator 227 208	less than
T24	Eq-Operator 391 366	<
T25	Eq-Operator 411 382	>
T26	Eq-Operator 580 545	less than
T27	Eq-Temporal-Unit 237 217	years
T28	Eq-Unit 165 152	mmol
T29	Age 217 198	age
T30	Eq-Value 89 82	24
T31	Eq-Value 134 125	10
T32	Eq-Value 160 147	4
T33	Eq-Value 231 211	18
T34	Eq-Value 401 372	20,000
T35	Eq-Value 414 383	5
T36	Eq-Value 584 548	24
T37	Eq-Comparison 95 88	<24 hours
T38	Eq-Comparison 169 154	>4 mmol/L
T39	Eq-Comparison 237 217	less than 18 years
T40	Eq-Comparison 395 368	<20
T41	Eq-Comparison 414 383	>5
T42	Eq-Comparison 590 554	less than 24 hours
T43	Condition 50 47	cirrhotics
T44	Condition-Name 50 47	cirrhotics
T1	Severity 35 32	Critically
T2	Condition 80 77	septic shock
T45	Condition-Name 80 77	septic shock
T46	Eq-Temporal-Unit 95 88	hours
T47	Drug 117 109	norepinephrine
T48	Drug-Name 117 109	norepinephrine
T49	And 102 94	with
T50	Modifier 67 64	early onset
T51	And 55 52	with
T52	Eq-Comparison 134 125	more than 10
T53	Eq-Operator 130 122	more than
T54	Eq-Unit 137 128	ug
T55	Eq-Temporal-Unit 143 132	min
T56	Observation 155 144	lactate
T57	Observation-Name 155 144	lactate
T58	Eq-Unit 169 154	L
T59	And 147 136	and
T60	Severity 249 229	Severe
T61	Modifier 292 271	structural
T62	Modifier 304 283	valvular
T63	Or 295 274	or
T64	Severity 366 341	Severe
T65	Observation 389 364	platelets
T66	Observation-Name 389 364	platelets
T67	And 405 376	and
T68	Condition 433 401	Bleed
T69	Condition-Name 433 401	Bleed
T70	Modifier 443 410	Mucosal
T71	Modifier 455 422	variceal
T72	Or 446 413	or
T73	Eq-Comparison 427 395	Active
T74	Eq-Temporal-Period 427 395	Active
T75	Modifier 486 451	Chronic
T76	Death 525 490	moribund
T77	Risk 525 490	moribund
T78	Observation 567 532	life expectancy
T79	Observation-Name 567 532	life expectancy
T80	And 539 504	with
T81	Eq-Temporal-Unit 590 554	hours
T82	Drug 721 683	vasopressors
T83	Drug-Name 721 683	vasopressors
T86	Condition 774 735	shock
T87	Condition-Name 774 735	shock
T88	Modifier 741 702	late presentation
T89	Modifier 765 726	spontaneous reversal
T90	Or 744 705	or
T84	Polarity 700 662	high
T85	Study 821 782	clinical trials
T91	Other 805 766	other
A1	Eq-Operator-Value T21 LT
A2	Eq-Operator-Value T22 GT
A3	Eq-Operator-Value T23 LT
A4	Eq-Operator-Value T24 LT
A5	Eq-Operator-Value T25 GT
A6	Eq-Operator-Value T26 LT
A7	Eq-Temporal-Unit-Value T27 year
A8	Severity-Value T1 severe
A9	Eq-Temporal-Unit-Value T46 hour
A10	Eq-Operator-Value T53 GT
A11	Eq-Temporal-Unit-Value T55 minute
A12	Observation-Type-Value T57 lab
A13	Severity-Value T60 severe
A14	Severity-Value T64 severe
A15	Observation-Type-Value T66 lab
A16	Eq-Temporal-Period-Value T74 present
A17	Eq-Temporal-Unit-Value T81 hour
A18	Observation-Type-Value T18 lab
A19	Polarity-Value T84 high
R1	Example-Of Arg1:E7 Arg2:E3
R2	Example-Of Arg1:E5 Arg2:E3
R3	Example-Of Arg1:E15 Arg2:E3
R4	Treatment-For Arg1:E41 Arg2:E19